76 related articles for article (PubMed ID: 28468901)
1. 0.2% chlorhexidine acetate as skin disinfectant prevents skin lesions in extremely preterm infants: a preliminary report.
Janssen LMA; Tostmann A; Hopman J; Liem KD
Arch Dis Child Fetal Neonatal Ed; 2018 Mar; 103(2):F97-F100. PubMed ID: 28468901
[TBL] [Abstract][Full Text] [Related]
2. 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial.
Clarke P; Soe A; Nichols A; Harizaj H; Webber MA; Linsell L; Bell JL; Tremlett C; Muthukumar P; Pattnayak S; Partlett C; King A; Juszczak E; Heath PT
Arch Dis Child Fetal Neonatal Ed; 2024 Feb; 109(2):202-210. PubMed ID: 37907266
[TBL] [Abstract][Full Text] [Related]
3. Results of the CHlorhexidine Gluconate Bathing implementation intervention to improve evidence-based nursing practices for prevention of central line associated bloodstream infections Study (CHanGing BathS): a stepped wedge cluster randomized trial.
Reynolds SS; Woltz P; Keating E; Neff J; Elliott J; Hatch D; Yang Q; Granger BB
Implement Sci; 2021 Apr; 16(1):45. PubMed ID: 33902653
[TBL] [Abstract][Full Text] [Related]
4. Bathing with wipes impregnated with chlorhexidine gluconate to prevent central line-associated bloodstream infection in critically ill patients: A systematic review with meta-analysis.
Peixoto EAC; Poveda VB; Gnatta JR; Oliveira RA
Am J Infect Control; 2024 Jun; 52(6):731-738. PubMed ID: 38342345
[TBL] [Abstract][Full Text] [Related]
5. Tegaderm CHG IV Securement Dressing for Central Venous and Arterial Catheter Insertion Sites: A NICE Medical Technology Guidance.
Jenks M; Craig J; Green W; Hewitt N; Arber M; Sims A
Appl Health Econ Health Policy; 2016 Apr; 14(2):135-49. PubMed ID: 26458938
[TBL] [Abstract][Full Text] [Related]
6. Comparative Effectiveness of 2 Chlorhexidine Gluconate-Containing Dressings in Reducing Central Line-Associated Bloodstream Infections, Hospital Stay, and Costs.
Hou Y; Griffin L; Bernatchez SF; Hommes J; Kärpänen T; Palka-Santini M
Inquiry; 2023; 60():469580231214751. PubMed ID: 38037829
[TBL] [Abstract][Full Text] [Related]
7. Chlorhexidine bathing of the exposed circuits in extracorporeal membrane oxygenation: an uncontrolled before-and-after study.
Yeo HJ; Kim D; Ha M; Je HG; Kim JS; Cho WH
Crit Care; 2020 Oct; 24(1):595. PubMed ID: 33023624
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous Microbiome Profiles Following Chlorhexidine Treatment in a 72-Hour Daily Follow-Up Paired Design: a Pilot Study.
Mougeot JC; Beckman MF; Bahrani Mougeot F; Horton JM
Microbiol Spectr; 2022 Jun; 10(3):e0175321. PubMed ID: 35467392
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of whole-body chlorhexidine gluconate cleansing with or without emollient in hospitalised neonates (NeoCHG): a multicentre, randomised, open-label, factorial pilot trial.
Russell N; Clements MN; Azmery KS; Bekker A; Bielicki J; Dramowski A; Ellis S; Fataar A; Hoque M; LeBeau K; O'Brien S; Schiavone F; Skoutari P; Islam MS; Saha SK; Walker AS; Whitelaw A; Sharland M
EClinicalMedicine; 2024 Mar; 69():102463. PubMed ID: 38426071
[TBL] [Abstract][Full Text] [Related]
10. Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review.
Derde LP; Dautzenberg MJ; Bonten MJ
Intensive Care Med; 2012 Jun; 38(6):931-9. PubMed ID: 22527065
[TBL] [Abstract][Full Text] [Related]
11. Practices to prevent central line-associated bloodstream infection: A 2021 survey of infection preventionists in US hospitals.
Pisney L; Camplese L; Greene MT; Saint S; Fowler KE; Chopra V
Infect Control Hosp Epidemiol; 2024 Apr; ():1-5. PubMed ID: 38654493
[TBL] [Abstract][Full Text] [Related]
12. Economic impact of Tegaderm chlorhexidine gluconate (CHG) dressing in critically ill patients.
Thokala P; Arrowsmith M; Poku E; Martyn-St James M; Anderson J; Foster S; Elliott T; Whitehouse T
J Infect Prev; 2016 Sep; 17(5):216-223. PubMed ID: 27582899
[TBL] [Abstract][Full Text] [Related]
13. Microneedle-Mediated Permeation Enhancement of Chlorhexidine Digluconate: Mechanistic Insights Through Imaging Mass Spectrometry.
Kirkby M; Sabri AB; Scurr D; Moss G
Pharm Res; 2022 Aug; 39(8):1945-1958. PubMed ID: 35689005
[TBL] [Abstract][Full Text] [Related]
14. Impact of measurement and feedback on chlorhexidine gluconate bathing among intensive care unit patients: A multicenter study.
Rhee Y; Hayden MK; Schoeny M; Baker AW; Baker MA; Gohil S; Rhee C; Talati NJ; Warren DK; Welbel S; Lolans K; Bahadori B; Bell PB; Bravo H; Dangana T; Fukuda C; Habrock Bach T; Nelson A; Simms AT; Tolomeo P; Wolf R; Yelin R; Lin MY;
Infect Control Hosp Epidemiol; 2023 Sep; 44(9):1375-1380. PubMed ID: 37700540
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Compatibility of a Gum Mastic Liquid Adhesive and Liquid Adhesive Remover With an Alcoholic Chlorhexidine Gluconate Skin Preparation.
Ryder M; Duley C
J Infus Nurs; 2017; 40(4):245-252. PubMed ID: 28683004
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial on healthy volunteers of pharmacokinetic and antimicrobial activity of a novel hydrogel-containing chlorhexidine dressing to prevent catheter-related bloodstream infection.
Masferrer E; Riera-Rodríguez L; Farré-Alins V; Vilà de Muga S; Arroyo-Muñoz FJ; González-Caro MD
Front Med (Lausanne); 2023; 10():1335364. PubMed ID: 38259833
[TBL] [Abstract][Full Text] [Related]
17. Global variation in skin injures and skincare practices in extremely preterm infants.
Jani P; Mishra U; Buchmayer J; Maheshwari R; D'Çruz D; Walker K; Gözen D; Lowe K; Wright A; Marceau J; Culcer M; Priyadarshi A; Kirby A; Moore JE; Oei JL; Shah V; Vaidya U; Khashana A; Godambe S; Cheah FC; Zhou WH; Hu XJ; Satardien M
World J Pediatr; 2023 Feb; 19(2):139-157. PubMed ID: 36372868
[TBL] [Abstract][Full Text] [Related]
18. Relationship between chlorhexidine gluconate concentration and microbial colonization of patients' skin.
Rhee Y; Simms AT; Schoeny M; Baker AW; Baker MA; Gohil S; Rhee C; Talati NJ; Warren DK; Welbel S; Lolans K; Bell PB; Fukuda C; Hayden MK; Lin MY;
Infect Control Hosp Epidemiol; 2024 May; ():1-6. PubMed ID: 38804007
[TBL] [Abstract][Full Text] [Related]
19. On the Acetate of Potash in Some Diseases of the Skin.
West J Med Surg; 1851 Jan; 7(1):90. PubMed ID: 38209839
[No Abstract] [Full Text] [Related]
20. Acetate of Potash in Some Diseases of the Skin.
Med Exam (Phila); 1851 Jan; 7(73):70. PubMed ID: 38121027
[No Abstract] [Full Text] [Related]
[Next] [New Search]
